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Introduction
Spinal dysraphism (SD) includes the overall group of
defects derived from the maldevelopment of the ecto-
dermal, mesodermal, and neuroectodermal tissues. SD
is categorized into open spinal dysraphism (OSD) and
closed spinal dysraphism (CSD).1 In OSD, the nervous
tissue is exposed to the environment, whereas in CSD,
the nervous tissue is covered by skin. The term spina
bifida is still commonly used as a synonym for SD,
although it properly refers to defective fusion of the
posterior spinal bony elements.2 The confusing terms
spina bifida aperta or cystica and spina bifida occulta
were once used to refer to OSD and CSD, respec-
tively,3 but have been progressively eliminated.
With advances in surgical and medical treatment,
long-term care for patients with SD has become an
important issue. The primary lesion of SD is in the spinal
portion of the central nervous system, but secondary
impairments may include joint deformities, reduced mo-
bility, fecal or urinary incontinence, hydrocephalus, and
cognitive dysfunction. Therefore, multidisciplinary clini-
cal follow-up involving professionals, such as pediatric
neurosurgeons, rehabilitation physicians, nephrologists,
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urologists, orthopedists, nurses, physical therapists,
and orthotists, is highly advocated.
Most studies have focused on patients with mye-
lomeningocele (MMC), which comprises the over-
whelming number of patients with OSD. Few reports
have been published on patients with CSD,4–7 in which
lipomyelomeningocele (LMMC) is the most com-
mon subtype.7,8 MMC and LMMC have similar clinical
presentations, except some kinds of central nervous
system involvement are rare among patients with
LMMC.7,8
Due to the diversity in terminology, cultural/ethnic
differences, and medical policies, prior study results
cannot be generalized to all populations. The aim of
this study was to describe the clinical features and
their correlation within patients in Taiwan with SD as
a clinical guide for future follow-up and management.
Methods
A cross-sectional study was conducted by telephone
interview among patients diagnosed with MMC or
LMMC since 1981 in our single center-based SD mul-
tidisciplinary clinic database. The semi-structured tele-
phone interview was performed by one of the authors
and data on symptomatic Arnold Chiari type 2 mal-
formations (ACM2), a history of ventriculoperitoneal
shunting, scoliosis, foot deformities, hip problems
(including hip subluxation, dislocation, and surgery),
use of assistive devices, wheelchair use, use of lower ex-
tremity orthotics or walking aids, the need for additional
assistive devices, complications from assistive device use,
hand function, bowel function, bladder function, and
ambulation status were collected. In addition, retro-
spective chart reviews were conducted and the following
data was collected: age, gender, family history, preg-
nancy history, prenatal or postnatal diagnosis, mode
of delivery, and neurologic level (S2 below, sacral;
L5/S1, lumbosacral; L3/L4, mid-lumbar; L1/L2,
high lumbar; thoracic). We also ranked assistive
device use (from the least to the most aggressive) for
wheelchairs (no wheelchair, manual wheelchair, pow-
ered wheelchair), lower-extremity orthotics (none,
insole or soft ankle brace, foot orthosis, ankle-foot
orthosis, knee-ankle-foot orthosis, hip-knee-ankle-
foot orthosis), and walking aids (none, cane, walker
used mostly indoors, forearm crutch, axillary crutch).
We performed both descriptive and statistical
analyses. All statistical analyses were conducted with
SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). 
A p value of 0.05 was set as indicative of statistical 
significance.
Results
There were 91 and 99 patients diagnosed with MMC
and LMMC in the database, respectively. We com-
pleted telephone interviews and chart reviews for 
39 patients in each group; thus, 78 patients were
included in this study. The reasons some patients
were not included were incorrect telephone numbers
(102 patients), loss of chart records (9 patients), and
death (1 patient).
General data and the clinical characteristics of our
subjects are listed in Table 1. Pregnancy and family
histories were without clinical significance and so are
not listed. The median age of the patients was 15.24 ±
6.74 years, and the percentage of male subjects was
57.7%. The overall cesarean section rate was 42.1%.
Only subjects with MMC had symptomatic ACM2
or a history of shunt placement and had been reported
to have lower hand function (significantly lower dex-
terity or muscle power compared with peers) or were
diagnosed prenatally. Subjects with MMC had higher
rates of scoliosis, foot deformities, hip problems, use of
assistive devices, wheelchairs, lower-extremity orthotics,
or walking aids, the need for additional assistive devices,
complications from assistive device use, and bowel/
bladder dysfunction than subjects with LMMC.
The distribution of neurologic and ambulation levels
is listed in Table 2. Five (12.8%) subjects with MMC and
18 (46.2%) with LMMC had no neurologic deficits.
No subjects with LMMC had a high neurologic level
(high lumbar plus thoracic). Neurologic involvement
was less severe in subjects with LMMC than in subjects
with MMC.
Most subjects (87.2%) with LMMC were commu-
nity ambulators, and approximately half of the subjects
(56.4%) with MMC were within this ambulatory status
(Table 2). Eleven subjects (28.2%) with MMC and 
3 subjects (7.7%) with LMMC were non-ambulators.
Ambulation prognosis was better in subjects with
LMMC.
The neurologic levels and corresponding ambulation
levels and assistive device use are listed in Table 3. Most
subjects (73.8%) with a low neurologic level (sacral plus
lumbosacral) were community ambulators, unlike those
with a high neurologic level. Ambulation status was
more variable in subjects with a mid-lumbar neurol-
ogic level. Manual wheelchairs, ankle-foot orthoses
and walkers were the most commonly used assistive
devices.
Spearman’s rank correlation of ambulation or neu-
rologic levels and other variables is listed in Table 4.
Ambulation level was significantly correlated with
neurologic level, history of shunt placement, and various
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orthopedic deformities. Neurologic level correlated with
history of shunt placement, various orthopedic defor-
mities, various assistive device use, need for additional
assistive devices, aggressiveness of assistive devices, and
bowel/bladder dysfunction.
Discussion
The prevalence of OSD has been decreasing worldwide
over the past 3 decades.9 This decline has been attributed
to improved maternal nutrition, periconceptional folic
Table 1. General data and clinical characteristics*
MMC LMMC Total
Cases 39 39 78
Age, yr 12.85 ± 4.65 17.64 ± 7.65 15.24 ± 6.74
Male:female 22:17 23:16 45:33
Pre:Post 5:31 0:36 5:67
VD:CS 19:19 25:13 44:32
Symptomatic ACM2 1 (2.6) 0 (0) 1 (1.3)
VP shunting history 24 (61.5) 0 (0) 24 (30.8)
Scoliosis 13 (33.3) 9 (23.1) 22 (28.2)
Foot deformities 27 (71.1) 22 (56.4) 49 (63.3)
Hip problems 6 (15.4) 3 (7.7) 9 (11.5)
Assistive device user 27 (69.2) 14 (35.9) 41 (52.6)
Wheelchair user 12 (30.8) 7 (17.9) 19 (24.4)
Manual wheelchair 11 (28.2) 7 (17.9) 18 (23.1)
Powered wheelchair 2 (5.1) 1 (2.6) 3 (3.8)
Lower-extremity orthosis user 22 (56.4) 11 (28.2) 33 (42.3)
Walking aid user 9 (23.1) 3 (7.7) 12 (15.4)
Need for additional device 14 (35.9) 9 (23.1) 23 (29.5)
Complication from device use 14 (35.9) 6 (15.4) 20 (25.6)
Lower hand function 7 (17.9) 0 (0) 7 (9.0)
Bowel dysfunction 37 (94.9) 18 (46.2) 55 (70.5)
Bladder dysfunction 37 (94.9) 20 (51.3) 57 (73.1)
*Data presented as n or mean± standard deviation or n (%). MMC = myelomeningocele; LMMC = lipomyelomeningocele; Pre = prenatal diagnosis; Post = postnatal
diagnosis; VD = vaginal delivery; CS = cesarean section; ACM2 = Arnold Chiari type 2 malformation; VP = ventriculoperitoneal.
Table 2. Distribution of neurologic level and ambulation level*
LMMC MMC Total
Neurologic level
No 18 (46.2) 5 (12.8) 23 (29.5)
S 7 (17.9) 7 (17.9) 14 (17.9)
LS 8 (20.5) 20 (51.3) 28 (35.9)
ML 6 (15.4) 3 (7.7) 9 (11.5)
HL 0 (0) 3 (7.7) 3 (3.8)
T 0 (0) 1 (2.6) 1 (1.3)
Ambulation level
Community 34 (87.2) 22 (56.4) 56 (71.8)
Household 2 (5.1) 6 (15.4) 8 (10.3)
Non-ambulator 3 (7.7) 11 (28.2) 14 (17.9)
*Data presented as n (%). LMMC = lipomyelomeningocele; MMC = myelomeningocele; No = no neurologic deficit; S = sacral; LS = lumbosacral; ML = midlumbar;
HL = high lumbar; T = thoracic.
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acid supplementation, wider availability of prenatal diag-
nostic tests with an increased incidence of elective ter-
minations, and other unknown reasons.10 However, SD
is still the second most common congenital birth defect
worldwide.11 MMC remains the most common congen-
ital neurological malformation compatible with life.10
MMC and LMMC have the same clinical presen-
tation in many aspects, such as lower extremity paralysis,
Table 3. Neurologic level and corresponding ambulation level and assistive device use
Neurologic level (no. of subjects)
No S LS ML HL T
Ambulation level
Community 22 12 19 3 0 0
Household 0 0 5 2 0 1
Non-ambulator 1 2 4 4 3 0
Assistive device use
Not using wheelchair 23 12 21 2 0 1
Manual wheelchair 0 2 5 7 2 0
Electric wheelchair 0 0 2 0 1 0
Total wheelchair use 0 2 7 7 3 0
Lower extremity orthosis use
None 19 10 13 2 1 0
Insole or ankle brace 0 1 1 0 0 0
Foot orthosis 2 1 0 0 1 0
Ankle-foot orthosis 2 1 12 6 1 0
Knee-ankle-foot orthosis 0 0 1 1 0 0
Hip-knee-ankle-foot orthosis 0 1 1 0 0 1
Total lower extremity orthosis use 4 4 15 7 2 1
Walking aid use
None 23 13 20 6 3 1
Cane 0 0 2 0 0 0
Walker 0 1 4 1 0 0
Forearm crutch 0 0 1 1 0 0
Axillary crutch 0 0 1 1 0 0
Total walking aid use 0 1 8 3 0 0
No = no neurologic deficit; S = sacral; LS = lumbosacral; ML = midlumbar; HL = high lumbar; T = thoracic.
Table 4. Spearman’s rank correlation between neurologic level or ambulation level and other variables
Neurologic level Ambulation level
Shunting history 0.370* Shunting history 0.500*
Scoliosis 0.344* Scoliosis 0.266†
Foot deformities 0.588* Foot deformities 0.325*
Hip problems 0.310* Hip problems 0.334*
Assistive device use 0.614* Neurological level 0.506*
Wheelchair use 0.538* Shunting history‡ 0.505*
Lower extremity orthosis use 0.431*
Walking aid use 0.294*
Need for additional device 0.457*
Bowel dysfunction 0.597*
Bladder dysfunction 0.589*
Wheelchair aggressiveness 0.535*
Lower extremity orthosis aggressiveness 0.464*
Walking aid aggressiveness 0.299*
Shunting history‡ 0.348†
*p < 0.01; †p < 0.05; ‡correlation was performed within the myelomeningocele group.
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sensory loss, musculoskeletal deformity, and neuro-
genic bladder. Nevertheless, hydrocephalus and ACM2
are generally not associated with LMMC.7,8 These
observations concur with our finding that no subjects
with LMMC had symptomatic ACM2, shunts placed
to resolve hydrocephalus, or lower hand function
which might have resulted from hydrocephalus or
ACM2.
Only 1 child (2.6%) with MMC had history of symp-
tomatic ACM2. The reason for this low prevalence
compared to that in another study12 with a prevalence
of up to 20% might be that not all of the subjects had
been followed-up since birth in our clinic. Symptomatic
ACM2 often occurs in the first few years of life and
has a relatively high mortality. Furthermore, the study
group comprised only 41.1% (78/190) of the original
sample. Lastly, there was poor comprehension of ACM2
by the parents.
No subjects with LMMC were diagnosed prenatally,
compared to 5 (13.9%) subjects with MMC. Prenatal
diagnosis of MMC is now routinely performed by
obtaining maternal serum α-fetoprotein and ultrasound
followed by amniocentesis or detailed sonography, if
indicated. In contrast, no reliable prenatal diagnostic
methods for LMMC exist. Only a few case reports13–15
have described the prenatal sonographic detection of
LMMC.
Patients and their families are often most concerned
at the time of diagnosis about the prognosis for ambu-
lation. The ambulation level was determined according
to Hoffer et al’s classification16 in our study, but ther-
apeutic (nonfunctional) ambulators and non-ambulators
were combined to the same level, since nearly all ther-
apeutic ambulators will become non-ambulators over
time.17,18 The Sharrard classification19 was used for
the neurologic level. In patients with MMC, neurologic
level was considered to be the determining factor influ-
encing ambulation.17,20–22 This general agreement also
applies to patients with other kinds of SD, including
LMMC,5 and was found in our study as well, with a
high Spearman’s rank correlation between neurologic
and ambulation levels. This also explains that subjects
with MMC had more severe neurologic involvement
as well as poorer ambulation outcome compared to
subjects with LMMC.
In addition to the neurologic level, there are addi-
tional prognostic factors, including upper motor neuron
signs such as spasticity, tethered cord, syringohydro-
myelia, ACM2,18,23,24 type of bracing,25,26 musculo-
skeletal deformities,16,17 changing social goals, larger
body mass due to maturation,27 a period of immobi-
lization,28 and even poor motivation.29 Such additional
prognostic factors could explain why some subjects
with a low neurologic level would have an unexpectedly
worse ambulation outcome. One extreme example was
a patient in our study without neurologic deficit, defined
by muscle power of the lower extremities, who was a
non-ambulator (Table 3). He had a symptomatic ACM2
and had received surgery. The sequelae, including spas-
ticity, cognitive dysfunction, possibly poor balance,
and poor muscle control, made him a non-ambulator.
This reveals the drawback of using neurologic level as
a single prognostic factor for ambulation.
In our study, scoliosis, foot deformities, and hip
problems had a negative impact on the subject’s ambu-
lation status. This was in agreement with previous
studies.16,17 Shunting history also exacerbated subjects’
ambulation status in our study. Since only subjects with
MMC would have a history of shunt placement, we
analyzed the correlation between ambulation and
shunting history within the MMC group. The result
also revealed the same negative impact. Some stud-
ies29,30 have suggested that multiple shunt revisions is
a risk factor for a poorer ambulation level. We did not
collect data regarding shunt revision, only shunting
history. Therefore, further studies are needed to clarify
the influence of shunt revision on the ambulation status
of our patients.
In addition to ambulation, neurologic level also
had a significant influence on many other variables 
in our study, as we had anticipated. Specifically, the
higher/worse the neurologic level, the higher the prev-
alence of shunting history, scoliosis, foot deformities,
hip problems, use of assistive device, use of wheelchair,
use of lower extremity orthotic, use of walking aid, need
for additional devices, and bowel/bladder dysfunction.
A history of shunt placement was not associated with
LMMC. Therefore, we performed a correlation test
between neurologic level and history of shunt placement
within the MMC group. The result was also significant,
and this concurred with the finding of a study4 that had
involved 142 subjects with OSD. The same study,4
with a total of 179 subjects with OSD or CSD, also
suggested that the higher the neurologic level, the
higher the prevalence of scoliosis and foot deformities.
Our findings, again, concurred with that. The neuro-
logic level was also associated with the type of assistive
device use, as we had anticipated. After we ranked
assistive device use from the least to the most aggressive,
we showed that subjects with a higher/worse neurologic
level used the more aggressive wheelchairs, lower-
extremity orthotics, and walking aids.
In a cross-sectional study31 with a sample size of
348 subjects (mean age, 18 years) diagnosed with
MMC, 52%, 5%, 35%, and 23% of the subjects used a
manual wheelchair, powered wheelchair, lower-extremity
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orthotic, and walking aid, respectively, compared to
28.2%, 5.1%, 56.4%, and 23.1% of the subjects in our
MMC group, respectively (Table 1). The percentages
of powered wheelchair users and walking aid users
were nearly the same between the 2 studies; however,
our subjects with MMC used the manual wheelchair less
frequently, but used lower-extremity orthotics more
often. The less frequent use of manual wheelchairs
might be due to the idea of wheelchair use representing
a handicap, of insufficient social welfare support for
wheelchair use in our nation, poor family economic
status, unrealistic ambulation goals, or other uniden-
tified factors. More of our subjects used lower extremity
orthotics than in a previous study.31 This discrepancy
is hard to explain; physician’s preference, local medical
policy, and parents’/patients’ attitudes might be possible
reasons, but these are just presumptions. The true causes
and all our presumptions require clarification through
further study.
Among the 41 subjects using assistive devices, 20
(48.8%) had experienced complications from device
use (Table 1). Skin breakdown, pain, and falls comprised
most of the complications, and all of the complica-
tions would usually cause a period of abstinence from
assistive device use, immobilization, or a deterioration
in ambulation status. This is a problem requiring seri-
ous treatment, by way of correct device prescription,
sufficient instructions about device use, and periodic
follow-up.
There were several limitations to our study. The first
was inherent in the cross-sectional nature of the study
by telephone interview. A variety of information could
not be convincingly collected by telephone interview.
We did not examine the patients directly, and the current
status of spasticity, contractures, scoliosis, foot defor-
mities, hip dislocations, other orthopedic deformities,
and the assistive device design were unclear. The preva-
lence might have been under-reported or even over-
reported for various reasons. The second limitation was
that many subjects in the original sample were not
included in the study sample. This might have had a
significant influence, although we assumed that the
incidence of having an incorrect telephone number,
the main reason for the subjects’ exclusion, should have
been distributed randomly throughout the original
sample. However, this was just our presumption. This
limitation also resulted in a relatively small study sample
size (78 subjects).
Even though there were limitations and presump-
tions within our study, we believe that this study can
serve as a background for further study designs, espe-
cially prospective studies with or without focusing on
a specific issue.
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